Will brings more than 15 years of experience in biopharmaceutical commercialization, including significant depth in oncology launch strategy, life-cycle management, pricing, and market access strategy

Recent examples of Will’s work include:

• Biosimilar defense strategy: Developed pricing, contracting, distribution, and value-added service program to minimize impact on multi-billion dollar immunology franchise
• Led product launch strategy and planning for multi-billion dollar opportunity in Hepatitis C; developed sales, marketing, and managed care marketing plans; built detailed long range forecasts based on TPP and developing market dynamics; developed pricing strategy and managed care engagement plan; identified opportunities for “game-changing” innovation with respect to value-based contracting options
• Led development of best-in-class provider and patient support program as cornerstone of novel go-to-market commercial model; determined optimal mix of support services, outcomes reporting tools, and digital platforms as mechanism by which to assure disproportionate share of new patient starts in competitive launch markets
• Developed go-to-market strategy and launch plans for multi-indication oncology product; determined core messaging across central marketing functions based on significant primary and secondary market research analysis

Prior to joining Strategy&, Will has worked in consulting at Deloitte, Oliver Wyman, and, most recently, at Campbell Alliance.  Will worked at Amgen in sales, marketing, life cycle management and licensing/M&A before his consulting career.